The road to commercialization: how our platform drives revenue
So how does Cyclica make money (or revenue)? This fundamental question is central to any business...
From molecule to medicine
The nexus between right and effective is where you win
Let’s face it, as business operators, technologists, scientists, and humans in general, we want to...
History and evolution of programming languages
Imperative Family Languages
The defining trait of imperative languages is that the programmer tells...
Rebranding Repurposing: a Polypharmacological Perspective
“Drug repurposing doesn’t work. We’ve all tried it and it doesn’t work.”
Employee Spotlight - Dennis Sarovski
I am Dennis Sarovski, a cybersecurity professional at Cyclica Inc. with a passion for both learning...
Embracing Limitations: How Assessment Informs Application
Over a year has now passed since DeepMind-EBI released 48 complete AlphaFold2 (AF2) proteomes. ...
How Cyclica's Innovation fuels our success and continuous drive to tackle low data targets
Over the years, many aspects of Cyclica’s business and technology have changed, sometimes...
Employee Spotlight - Mohesan Sreekuladevan
Mohesan (Moe!) is the Team Lead of the Data & Web Platforms team at Cyclica. Having worked at...
Drug Discovery on the Dark Proteome - Delivering Tomorrow's Medicines
The role of a given protein(s) to a specific disease or indication is a fundamental aspect of drug...
Employee Spotlight - Omorinola Odeyinka
Omorinola is a shy (you'd never know) but courageous woman who enjoys coordination and planning,...